Brendan Luey

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

JMIR research protocols

This page only lists publications with an associated author ORCID identifier.

Publications

Phyu Sin Aye, Joanne Barnes, George R Laking, Laird Cameron, Malcolm Anderson, Brendan Luey, Stephen Delany, Dean Harris, Blair McLaren, Elliott Brenman, Jayden Wong, Ross Lawrenson, Michael Arendse, Tin Tin Sandar, J Mark Elwood, Philip Hope, Mark James McKeage
Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation-Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation Substudy. JMIR research protocols 13 (2024)
Phyu Sin Aye, Joanne Barnes, George R Laking, Laird Cameron, Malcolm Anderson, Brendan Luey, Stephen Delany, Dean Harris, Blair McLaren, Elliott Brenman, Jayden Wong, Ross Lawrenson, Michael Arendse, Tin Tin Sandar, J Mark Elwood, Philip Hope, Mark James McKeage
Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation-Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation Substudy. JMIR research protocols 13 (2024)
Phyu Sin Aye, Joanne Barnes, George R Laking, Laird Cameron, Malcolm Anderson, Brendan Luey, Stephen Delany, Dean Harris, Blair McLaren, Elliott Brenman, Jayden Wong, Ross Lawrenson, Michael Arendse, Tin Tin Sandar, J Mark Elwood, Philip Hope, Mark James McKeage
Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation-Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation Substudy. JMIR research protocols 13 (2024)